Christopher Jh Porter

44PUBLICATIONS
91CO-AUTHORS
Pharmaceutical delivery technologiesAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteinsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Apr 02, 2026
The expanding role of formulations to enable oral delivery of poorly water-soluble drugs.

Keisuke Ueda, Christopher J H Porter, Aaron Goodwin

|Mar 25, 2026
An oral allopregnanolone prodrug bypasses liver metabolism via lymphatic transport enabling bioavailability in animals and humans.

Jamie S Simpson, Tim Quach, Sifei Han

|Mar 17, 2026
Dysfunctional adipose tissue-lymphatic crosstalk in obesity.

William De Nardo, Andrea Y Chan, Christopher J H Porter

|Jan 27, 2026
Removal of Interstitial Hyaluronan Facilitates Subcutaneous Administration and Lymphatic Delivery of Anti-CTLA4 and Improves Antitumor Efficacy.

Gracia Gracia, Enyuan Cao, Daniel Yuen

|Aug 04, 2025
A versatile antibody capture system drives specific in vivo delivery of mRNA-loaded lipid nanoparticles.

Moore Z Chen, Daniel Yuen, Victoria M McLeod

|Feb 11, 2025
Optimizing Triglyceride Prodrugs of a Model Immunomodulator: Conjugation through the Phenol of Mycophenolic Acid (MPA) Markedly Promotes Lymphatic Drug Transport.

Luojuan Hu, Tim Quach, Dan Zheng

Pageof 8

Frequent Collaborators

10 joint publications

Natalie L Trevaskis

9 joint publications

Orlagh M Feeney

6 joint publications

Angus P R Johnston

6 joint publications

Colin W Pouton